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Chlorpyrifos is a moderately toxic organophosphate pesticide. Houses and lawns in the United
States receive a total ofapproximately 20 million annual chlorpyrifos treatments, and 82% of
U.S. adults have detectable levels ofa chlorpyrifos metabolite (3,5,6-trichloro-2-pyridinol; TCP)
in the urine. The U.S. Environmental ProtectionAgencyhas estimated thatthere are 5,000yearly
reported cases ofaccidenta chiorpyrifos poisoning, and approximately one-fourth ofthese cases
exhibit symptoms. Organophosphates affect the nervous system, but there are few epidemiologic
data on chlorpyrifos neurotoxicity. We studied neurologic function in 191 current and former
termiticide applicators who had anaverageof2.4 years applyingchlorpyrifos and 2.5 years apply-
ing other pesticides, and we compared them to 189 nonexposed controls. The average urinary
TCP level for 65 recently exposed applicators was 629.5 pg/L, as compared to 4.5 pg/L for the
general U.S. population. The exposed group did not differ significantly from the nonexposed
group for any test in the clinical examination. Few significant differences were found in nerve
conduction velocity, arm/hand tremor, vibrotactile sensitivity, vision, smell, visual/motor skills,
or neurobehavioral skills. The exposed group did notperform aswell as thenonexposedgroup in
pegboard turning tests and some postural sway tests. The exposed subjects also reported sigfi-
cantlymore symptoms, including memoryproblems, emotional states, fatigue, and loss ofmuscle
strength; our morequantitative tests maynothave been adequate to detectthese symptoms. Eight
menwho reported past chlorpyrifos poisoning had apattern oflowperformance on a number of
tests, which is consistent with prior reports of chronic effects of organophosphate poisoning.
Overall, the lack ofexposure effects on the clinical inaton was reassuring. Thefindings for
self-reported symptoms raise some concern, as does the finding of low performance for those
reporting prior poisoning. Although this was a relatively large study based on awell-defined tar-
getpopulation, theworkers westudied maynotbe representative ofallexposedworkers, and cau-
tion should be exercised in generalizing our results. Key wordr. chlorpyrifos, neurotoxicity,
organophosphates. EnvironHealthPerspect108:293-300 (2000). [Online 18 February2000]
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Chlorpyrifos ( O0-diethyl O-3,5,6-trichloro-
2-pyridyl phosphorothioate) is an organo-
phosphate pesticide used in both agricultural
and residential pest control. It exhibits mod-
erate acute toxicity, readily inhibiting plasma
cholinesterase at low doses and inhibiting
red blood cell cholinesterase at high doses
(1). Like all organophosphates, chlorpyrifos
can cause acute poisoning; well-known
symptoms include miosis, increased urina-
tion, diarrhea, diaphoresis, lacrimation, and
salivation (2).
Chlorpyrifos was first marketed in 1965.
Its use has increased rapidly, in part due to
the banning of chlordane for termite appli-
cations in 1988. The principal manufacturer
of chlorpyrifos (Dow Elanco, Indianapolis,
IN) has estimated that chlorpyrifos-contain-
ing products are applied in and around
American homes more than 20 million times
a year (3). In a survey ofa random sample of
U.S. adults (n = 929) conducted in the late
1980s and early 1990s, Hill et al. (4) esti-
mated that detectable levels of a metabolite
of chlopyrifos (3,5,6-trichloro-2-pyridinol;
TCP) are present in the urine of 82% of
U.S. adults, with a mean level of 4.5 pg/L.
TCP is largely specific for chlorpyrifos,
although two other less common pesticides,
chlorpyrifos-methyl and triclopyr, can also
be metabolized to TCP. Agricultural use of
chlorpyrifos is also common, accounting for
about two-thirds ofchlorpyrifos sales (5).
U.S. Environmental Protection Agency
(EPA) investigators summarized chlorpyrifos
poisoning data based on reports from poison
control centers and concluded that "chlor-
pyrifos is one of the leading causes of acute
insecticide poisoning incidents in the United
States (6)." U.S. poison control center data
for 1993-1994 (6) showed approximately
4,000-5,000 reported cases ofunintentional
chlorpyrifos exposures per year, with approx-
imately half of these exposures in adults.
Approximately 50% of the cases were fol-
lowed in more detail, and approximately half
ofthese were judged to have symptoms con-
sistent with clinical poisoning (85% with
minor symptoms and 15% with moderate or
severe symptoms). A subsequent analysis of
this same database (3) reported similar num-
bers. The large number of reported cases is
consistent with the widespread use of
chlorpyrifos; the data do not suggest that
chlorpyrifos is disproportionately responsible
to acute poisonings as compared with other
organophosphates.
The potential of chlorpyrifos to cause
chronic neurotoxic effects, either because of
low level chronic exposure or as sequelae to
acute poisoning, is controversial. Based on
animal data, chlorpyrifos can cause a mild
delayed peripheral neuropathy subsequent to
inhibition ofneurotoxic esterase (NTE), but
only at lethal levels [above the median lethal
dose (LD50)] after prophylaxis against
cholinergic toxicity (1). There are few epi-
demiologic data on the subject. There are
two case reports of delayed peripheral neu-
ropathy in humans following ingestion of a
nearly lethal dose (7,8). Steenland et al. (9)
found slower peroneal nerve conduction in
10 men previously poisoned by chlorpyrifos
as compared to 90 nonpoisoned subjects;
they also observed decreased performance in
finger vibrotactile sensitivity and worse self-
reported emotional moods in 17 men poi-
soned by a mixture of organophosphates,
including chlorpyrifos. However, no differ-
ences were seen on a large number of other
neurologic tests.
There are three limited studies regarding
neurologic effects attributable to chronic low-
level exposure. Ames et al. (10) conducted a
cross-sectional telephone survey of 68
California pet handlers who used chlorpyrifos
to treat fleas. These workers reported signifi-
cantly higher incidences of blurred vision,
flushing of skin, and decreased urination, as
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compared to nonexposed subjects. Two of
these symptoms are consistent with chronic
poisoning, but the finding for decreased uri-
nation is contradictory. Burns et al. (11)
studied 496 men potentially exposed to
chlorpyrifos during the manufacturing
process and 911 matched nonexposed con-
trols. Exposed subjects did not differ from
controls for most medical conditions, but
they did report significantly more general ill-
defined conditions (dizziness, fever, malaise,
fatigue), which were more common in sub-
jects with a history of cholinesterase inhibi-
tion. This study (11) was limited because the
authors relied on medical data obtained at
work from subjects who were self-referred
and by the lack of data on neurologic out-
comes after exposure. Kaplan et al. (12) pre-
sented data on a case series ofeight subjects
who were reportedly exposed to chlorpyrifos
and who subsequently exhibited a mild sen-
sory neuropathy and some memory prob-
lems; the documentation ofexposure in this
study is weak.
In light of some suggestive evidence in
the literature regarding chronic neurologic
effects ofexposure and thewidespread use of
chlorpyrifos in the United States, we con-
ducted a cross-sectional study ofneurologic
function among current and former termiti-
cide applicators who had used or were using
chlorpyrifos; chlorpyrifos has been the main
termiticide used in the United States since
chlordane was banned in 1988.
Methods
Exposedpopulation. The exposed popula-
tion in our study was made up of current
and former termiticide applicators using
chlorpyrifos in a 12-county area of North
Carolina; these subjects were identified from
lists of professional applicators provided by
the state ofNorth Carolina (Department of
Agrigulture, Raleigh, NC). Because some
termiticide applicators used chlordane before
1988, we included the use of chlordane
[reported in one study to have delayed neu-
rotoxiceffects (13)] in the analyses.
After identifying all pest control opera-
tors from 1987-1997 in the 12-county area,
we asked pest control companies to deter-
mine which employees had ever worked as
termiticide applicators. We asked termiticide
applicators reported to have ever worked for
a year or more to volunteer for the study;
subjects were contacted first bymail and then
by telephone. Recruiting continued until
approximately 200 termiticide applicators
had been scheduled for testing.
Participants (exposed and nonexposed)
were asked to undergo approximately 6 hr of
tests at a central location, within a 2-hr drive
for all eligible participants. Testing was con-
ducted on eight consecutive weekends in
1998. All participants received compensation
($250.00) for their time.
Nonexposedpopulation. Approximately
one-half of the exposed subjects were asked
to bring a friend ofthe same sex and approx-
imately the same age (within 5 years) to the
testing site. Recruitment of friend controls
was stopped when we reached approximately
100 controls. A second nonexposed group
was then chosen from lists of blue-collar
North Carolina State employees (mainte-
nance workers and corrections officers) liv-
ing in central North Carolina. We mailed a
request for volunteers to 856 blue-collar
state workers in four state departments. All
volunteers were included if they matched
the overall age, race, and sex distribution of
the already recruited applicators and ifthey
had never worked with pesticides or been
poisoned bypesticides.
The use of two nonexposed groups pro-
vided a check on the validity ofany possible
exposure effect. A true exposure effect would
be expected to be seen in relation to both
nonexposed groups, barring any selection
biases in choosing either group. If consistent
discrepancies are found between the two con-
trol groups, a systematic selection bias could
be present in one ofthem. The advantage of
friend control groups is that subjects are likely
to be similar to the members of the exposed
group in lifestyle and demographic variables;
the potential disadvantage is thatsubjects may
represent a select group, which is more socia-
ble and perhaps more likely to perform better
on some oftheneurologic tests.
Interview and alcohol tests. All partici-
pants provided informed consent and then
completed an interviewthat focused on demo-
graphic variables and a complete work history
(termiticide use, other pesticide use, solvent
use, job history). We asked all participants to
refrain from alcohol consumption on the
night before testing. We administered an alco-
hol saliva test on the morning ofthe test, and
any individuals with an alcohol concentration
> 0.03% wereasked to return at alater time.
Neurologic tests. We conducted neuro-
logic tests for both central and peripheral
function; testers were blind to exposure sta-
tus. All tests had been used previously in
other epidemiologic studies (14,15).
Neurobehavioral Evaluation System.
The Neurobehavioral Evaluation System
(NES) is used primarily to measure cognitive
functions (16). This system includes the fol-
lowing tests: a) the vocabulary test, which is
a measure of education; b) mood scales,
which measure the participants' self-reported
transient states of tension, depression, anxi-
ety, fatigue, and confusion; c) the digit span
test, which requires memorizing and repli-
cating a series ofnumbers as fast as possible;
a) continuous performance, which requires
pressing a key quickly when a certain letter
appears in a temporal sequence of letters; e)
simple reaction time, which measures how
fast one can respond to a visual stimulus by
pushing a button; J) the symbol-digit test,
which requires matching digits to symbols as
fast as possible following an exhibited
matched pattern; and g) the pattern memory
test, which requires selection ofa previously
seen pattern outofthree similar patterns.
Vlbrotactile test. The vibrotactile sensi-
tivity test measures peripheral nerve function
(sensory) by testing the sensitivity of the
individual to feeling a vibration, both in the
finger and the toe (nondominant). The fully
automated test (Vibrometry System-Bruel &
Kjcer, Naerum, Denmark) was conducted at
two vibration frequencies (31.5 Hz and 125
Hz) over an intensity range of90-160 dB.
Arm/hand tremor. The arm/hand
tremor test provides one measure ofperipher-
al nerve function (17). We measured tremor
using a NIOSH-developed hand-held device
that measured tremor via accelerometers
(18). The instrument can detect both visible
(e.g., 1-6 hertz) and nonvisible (e.g., 7-30
hertz) tremor. Analyses included horizontal
tremor and vertical tremor, both averaged
over each minute ofa 3-min test.
Postural sway. We used the postural sway
test (which is analogous to the Romberg dini-
cal test) to measure postural stability during
30-sec tests. We used a microcomputer-con-
trolled force platform (Advanced Mechanical
Technology Instruments, Newton, MA) and
varied test conditions (eyes open or closed,
hard or soft platform, one leg or two legs)
(19,20). Because of some initial confusion
about the test protocol, 49 subjects (13%)
wore shoes during this test; thus, we included
a dichotomous variable for wearing shoes in
all models. A number ofparticipants failed to
complete the full 30-sec test for the one-
legged tests (7% left leg, 12% right leg).
Manual dexterity. We used a grooved-
pegboard timed test to measure manual dex-
terity. Participants were required to insert 25
grooved pegs into a board, once with each
hand. The test is similarto the Santa-Anatest,
but requires more finepsychomotorcontrol.
Eye-hand coordination (two tests, trails
A and B). This test is a timed visuomotor
tracking task, which requires each participant
to use apencil to connect consecutively num-
bered orlettered circles as fast as possible.
Vision. Because exposure to pesticides
can affect vision (15,21), we performed stan-
dard visual tests ofacuity and contrast sensi-
tivity (22) using the OPTEC 1000 (Stereo
Optical, Chicago, IL), an automated visual
test system. V-isual acuity was measured on a
scale of0-7 (20/200 to 20/20) with corrected
vision (contacts or glasses). Contrastwas mea-
sured for each eye at five spatial frequencies
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with increasing level of difficulty. In the
analysis, we tested differences between
exposed and nonexposed subjects for visual
acuity, for each ofthe contrast tests, and for
the average of the last three (more difficult)
contrast tests after restricting the data set to
those with good visual acuity (either 6 or 7,
20/30 or better).
Color vision was tested by using two
other standard tests, the Farnsworth D-15
and the Lanthony D-15d tests (23); these
tests are used to determine congenital and
acquired color vision loss, respectively. Each
test consists of15 colored caps that the partic-
ipant must arrange in order bycolor, each cap
next to the cap dosest to it in color. We iden-
tified individuals with congenital color vision
loss in either one or both eyes using the
Farnsworth test and removed them from the
analysis ofacquired color vision loss based on
results ofthe Lanthony test. Tests were scored
using the Bowman method, which produces a
quantitative score based on the sum of the
colordifferences ofthe caps (24).
Olfaction (cross-cultural smell identifi-
cation test). Recent reviews have indicated
possible effects of pesticides on the sense of
smell (15,25). In the cross-cultural smell
identification test, the participant must
scratch and smell the 12 microencapsulated
odors and choose the perceived odor from
four choices (26). The odors were originally
prepared for the University of Pennsylvania
Smell Identification Test (UPSIT) (26). We
analyzed either the number ofodors (out of
12) correctly identified or the age-adjusted
percentile ofcorrectly identified smells.
Nerve conduction velocity. We mea-
sured nerve conduction velocity (time from
stimulation to depolarization) and peak
amplitude (the size ofthe maximal response
of the compound action potential) by using
surface electrodes in three nerves ofdominant
limbs (peroneal motor, sural, and ulnar senso-
ry nerves) at 33.0°C for the lower limb and
32.0°C for the upper limb. Motor responses
were orthodromic, whereas sensory responses
were antidromic. We expected peripheral
effects on nerve conduction in the lower
limbs with longer nerves (peroneal motor,
sural sensory); in some participants the sural
response was difficult to measure and the
ulnar (in thearm) served as asubstitute.
Clinical examination. A brief (15 min)
clinical neurologic examination was conduct-
ed on all participants by two neurologists;
both neurologists were trained to ensure that
their methods were comparable. The exami-
nation consisted ofobservation ofpupils and
eye movement, tremor, coordination, tone,
strength, sensation, reflexes, station, and gait.
Analyses were restricted to those end points
in which more than 10 participants were
judged to be abnormal.
Questionnaire. We used a short 24-item
self-administered questionnaire to deter-
mine neurologic symptoms in the last
month (e.g., "in the past month have you
experienced trouble remembering," "loss of
muscle strength," "numbness or tingling in
toes," "lack of coordination or loss of
balance"). This is a modified form of the
traditional Hogstedt symptom questionnaire
(22'); each question has five possible ordered
responses. Analyses considered either contin-
uous data or dichotomized data (i.e., "not at
all" vs. all higher categories combined),
depending on the response variability.
Biologic samples: urine and buccal
swabs. Applicators who had reported current
exposure during a phone interview a few
weeks before testing (n = 105) collected urine
samples (first void) and brought them to the
testing site. TCP, a metabolite largely specific
to chlorpyrifos (half-life approximately 27
hr), was measured in the urine. We also mea-
sured TCP in samples from 52 nonexposed
participants. We retained approximately 25
mL urine for analysis of TCP by gas chro-
matography by a commercial laboratory. The
laboratory's limit ofdetection for TCP by gas
chromatography is 2 ng/mL (28). We also
measured creatinine.
We obtained buccal cells to determine
the genotype of participants with regard to
paraoxonase, an enzyme that is instrumental
in detoxifying chlorpyrifos (29,30). The gene
for paraoxonase at amino acid 54 (chromo-
some 7) exhibits a polymorphism in humans.
Individuals homozygous for methionine, rep-
resenting about 15% of the population, are
likely to exhibit lower serum concentrations
ofthe enzyme (31,32) and would be expect-
ed to be more susceptible to neurotoxicity
due to chlorpyrifos oxon, the neurotoxic
metabolite ofchlorpyrifos. We obtained buc-
cal swabs from all ofthe exposed subjects and
from a sample of55 nonexposed participants
to ensure that the exposed and nonexposed
subjects exhibited a similar distribution ofthe
polymorphism.
We isolated DNA from buccal swabs
using a commercially available kit (Epicentre
Technologies, Madison, WI). We then ampli-
fied the paraoxonase gene from the DNA by
polymerase chain reaction (PCR) using
primers specific for sequences in the gene
(33). We assayed the amplified paraoxonase
gene for differences in DNAsequence at posi-
tion 54 using a colorometric method specific
for each allele (34).
Data analysis. In our data analysis we
focused on comparing results ofthe neurolog-
ic tests ofthe exposed subjects versus the non-
exposed subjects. We used linear regression
for this purpose and adjusted for possible
confounding variables. We used logistic
regression for some outcomes that were
dichotomous or polychotomous (e.g., all clin-
ical examination outcomes, and some vision
and symptom outcomes). We also used pro-
portional odds models for some polychoto-
mous outcomes, but these are not reported.
We checked demographic variables for
potential confounding effects and inclusion
in regression models. We constructed a basic
model that included variables of a priori
interest for most tests, i.e., age (continuous),
race (white/nonwhite), and education (less
than high school, high school, some college,
and college graduate), as well as avariable for
current smoking, which proved to be predic-
tive for several tests. We did not adjust for
sex; there were only six women in the study
population, and we found no evidence of
gender effects. For tests of peripheral neu-
ropathy (e.g., nerve conduction, vibration
sensitivity, tremor, sway, clinical examina-
tion), we also routinely included body mass
index. We tested other variables, such as
hours ofsleep the night before, alcohol con-
sumption the night before, current exposure
to solvents, and coffee consumption the day
ofthe tests, to explore possible confounding,
but these variables were generally not predic-
tive of outcome and were not included in
the final models. In addition, we checked
tests ofperipheral neuropathy for the poten-
tial confounding effects of a history of dia-
betes (n = 12), carpal tunnel syndrome (n =
12), nerve disorder (n = 17), nerve injury (n
= 16), or back disorder (n = 66); these vari-
ables in general did not act as confounders.
We tested whether the exposed group
differed from both nonexposed groups com-
bined for each outcome and for each control
group separately. Results are reported for
both control groups combined unless they
differed by control groups; in this case, they
are reported separately. After comparing the
exposed subjects to the nonexposed subjects,
we ran further models in which we com-
pared a variety ofexposed subgroups to the
nonexposed group; these included a) work-
ers currently applying termiticide in 1998 (n
= 128), b) workers formerly applying ter-
miticide (n = 63), c) workers with self-
reported poisoning by chlorpyrifos (n = 8),
and a) workers with a susceptible genotype
(n = 18). Within the applicator group we
also tested trends by duration ofexposure to
chlorpyrifos, chlordane, and other pesticides.
We also ran models, after restricting the data
to those with TCP values (n = 157), in
which we determined if higher TCP levels
(reflecting recent exposure) were associated
with the neurologic outcomes; log of TCP
and TCP corrected for creatinine were also
considered, but these generally did not
improve the fit ofthe model to the data.
We assessed all linear regression models
for model fit (R2) and checked residuals for
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normality; we made log transformations of
outcome as needed to normalize residuals.
There were a large number of comparisons.
We made no formal statistical correction
for multiple comparisons (e.g., Bonferroni),
but we interpreted the overall results with a
view toward consistency and biologic plausi-
bility (35).
Results
Studyparticipants. We identified 3,605 pest
control applicators who had been licensed by
the state of North Carolina from 1987 to
1997 in the 12-county target area. These
employees worked in 246 pest control com-
panies. We contacted 176 of these compa-
nies to obtain information about whether
their employees had worked as termiticide
applicators ("screened" employees). Another
71 companies were out of business and 6
refused to provide information (representing
"unscreened" employees). There were 2,917
(81%) screened employees and 688 (19%)
unscreened employees. Ofthe 176 pest con-
trol companies contacted, 105 (60%) report-
ed current (n = 76) or past (n = 29) use of
chlorpyrifos-containing pesticides.
Of the 2,917 screened candidates, 383
(13%) were reported to have worked apply-
ing termiticides for at least a year. Ofthese,
we were able to contact 239 (62%); we
could not locate the remaining 144 (38%),
despite extensive efforts. Ofthe 239 subjects
located, 13 reported never having worked as
termiticide applicators (5%), 68 refused to
participate (28%), 5 were not available dur-
ing the study period (2%), and 153 were
scheduled to be tested (64%).
We then sought other exposed partici-
pants for the study among the unscreened
group of 688 licensed applicators to reach
our target population of 200 termiticide
applicators. We tracked 206 individuals in
this group; we could not locate 78 (38%),
69 were ineligible (33%), 16 refused or
could not participate during the testing peri-
od (8%), and 43 (21%) were scheduled.
We tested 193 applicators of the 196
scheduled to be tested; 2 applicators
were dropped because they had not worked
as termiticide applicators and 1 was dropped
because he failed to complete the question-
niare.
We tested 106 "friend" controls who were
identified by the applicators, and 83 North
Carolina blue-collarstateemployees.
Table 1 shows the demographic charac-
teristics of the termiticide applicators and
the nonexposed participants. Exposed and
nonexposed participants were similar, but
the exposed subjects had somewhat less
education. We found no significant differ-
ence in education between applicators and
both nonexposed groups combined (p =
0.19; chi-square test), but there was a bor-
derline difference between applicators and
nonexposed state employees (p= 0.07).
Table 2 shows some exposure character-
istics of termiticide applicators. Applicators
had worked a median of 1.8 years (range
0.1-10.3) applying termiticides, but 90%
had also done other pest control work
(median 1.6 years; range 0.5-11.3). We
tried to restrict our exposed population to
those who had worked at least 1 year apply-
ing termiticides on the basis of employer
reports, but upon detailed interview at the
study site, we found that 57 applicators
(30%) had worked < 12 months in this field.
We then decided to include these subjects
and observe the effect of duration of expo-
sure in the analysis. Two-thirds ofthe appli-
cators had applied termiticides in 1998,
whereas the remainder were former applica-
tors. One-third of the applicators had
worked with chlordane, which was largely
replaced by chlorpyrifos in 1988. TCP levels
were quite high in applicators who reported
termite work in the last week (n = 65) as
compared to those who did not (n = 40).
Some elevated levels in applicators who did
not report applying termiticides in the last
week resulted from other uses ofchlorpyrifos
(e.g., on lawns or in interiors ofhouses). The
mean TCP level in 52 nonexposed partici-
pants was 6.2 pg/L; this is similar to the
mean level of4.5 pg/L observed in a random
sample of929 U.S. adults (4).
There are few data on chlorpyrifos expo-
sure levels in other occupationally exposed
workers to compare with data on termiticide
applicators. Brenner et al. (36) estimated that
time-weighted averaged air levels based on
personal samples range from 10 to 120 pg/m3
among chlorpyrifos-manufacturing workers.
In work done as part ofthis study, Hines (37)
reported a median full-shift air level of 14
pg/m3 chlorpyrifos for 16 termiticide opera-
tors (range 2-126). Fenske and Elkner (38)
studied six chlopyrifos applicators and found
a median air concentration of 10 pg/m3
(range 2-35) over a full shift. These data
suggest that termiticide applicators and man-
ufacturing workers may be similarly exposed,
although most absorption is probably dermal
and comparative air levels may not reflect
comparative dermal exposure. In any case,
the urinary TCP levels show that the termiti-
cideworkerswestudiedwereexposed to levels
two orders of magnitude above background,
making them a reasonable population in
which to studyexposureeffects.
By genotyping the paraoxonase gene in
184 termiticide applicators (7 samples could
not be genotyped), we determined that 18
(10%) were homozygous for the gene which
is responsible for potentially producing a low
level ofparaoxonase; these applicators might
be expected to be more susceptible to the
effects ofchlorpyrifos. A sample of 52 non-
exposed participants showed a similar pro-
portion ofhomozygotes (9%).
Nerve conduction. There were no signifi-
cant differences (at the a = 0.05 level)
between applicators and thecombined nonex-
posed group for peroneal, ulnar, or sural
nerve conduction velocity or amplitude.
When compared to each nonexposed group
separately, the only significant finding was
that the applicators had significantlyless ulnar
amplitude (p = 0.03) than state employees.
We found no significant differences in sub-
groups ofapplicators (current applicators, for-
mer applicators, susceptible genotype, previ-
ously poisoned) from the two nonexposed
groups combined, with the exception of the
eight poisoned men who had significantly
more ulnar amplitude. Currently exposed
applicators had significantly lower ulnar
amplitude (p = 0.03), but significantly faster
sural nerve conduction (p = 0.05), than state
employees. We found no significant trends
among applicators by duration ofexposure to
either chlorpyrifos, chlordane, or other pesti-
cides, nor was there any trend found by the
level ofTCP in the urine. Using models for
Table 1. Demographic characteristics of study participants.
Applicators Nonexposed Nonexposed NC
Characteristic (n= 191) friends (n= 106) workers (n= 83)
Mean age(SD) 39.3 (9.4) 38.0(9.7) 42.6 (8.7)
Education (%)
Less than high school 12.6 15.2 4.6
High school 33.5 35.8 43.3
Some college 44.5 33.0 40.1
Completed college 9.4 16.0 12.0
Mean body mass indexa(SD) 28.7 (5.7) 28.4(5.4) 29.3 (5.7)
Percent current smokers 36.1 49.0 42.6
Percent current alcohol drinkers 37.2 32.1 33.7
Percent with history of OSE 36.1 50.0 51.8
Percentwith current OSE 19.9 30.2 33.7
Diabetic 6 2 4
Race (% white) 81.6 81.6 86.8
Abbreviations: NC, North Carolina; OSE, occupational solvent exposure.
TBody mass index = weight(in kilograms)/height (in square meters).
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nerve conduction velocity, we were able to
explain approximately 10% ofthe variance.
Sway, tremor, and vibrotactile sensitivi-
ty. We conducted 12 sway tests comparing
exposed to nonexposed subjects for length or
area ofsway under increasingly difficult con-
ditions: standing on a hard surface with eyes
open and closed, standing on a soft pad with
eyes open and closed, and two one-legged
tests (eyes open, hard surface). The length
and area of sway were correlated, with a
Spearman correlation coefficient ofapproxi-
mately 0.60-0.70 for the 12 tests.
Exposed subjects differed significantly
from nonexposed subjects onlyfor one test-
the length ofswayon ahard surfacewith eyes
open (p = 0.04). This effect was more pro-
nounced when applicators were compared to
nonexposed friends (p = 0.05) than when
they were compared to nonexposed state
employees (p = 0.20). Separate comparisons
of the exposed group to each nonexposed
group revealed that the exposed subjects also
had more length ofsway than friend controls
on a hard surface with eyes closed (p = 0.07),
more area of sway than friend controls on a
hard surface with eyes closed (p = 0.10), and
more length of sway than state employee
controls while standing on the left legonly (p
= 0.01). The R2 for these models ranged
from 0.07 to 0.29, increasing with increasing
difficulty ofthe test.
The TCP level significantly predicted the
length of sway for the test conditions with
eyes closed (hard surface, p = 0.03; foam pad,
p = 0.01) and areaofsway for eyes closed on a
foam pad (p = 0.02). The findings for length
of sway, however, were no longer significant
after one participant with a high TCP level
was removed from the analysis (p = 0.18 for
both hard surface and foam pad). The R2 for
these models was 0.20-0.30.
An increased area ofsway for a subgroup
of the exposed group, the eight men who
reported past poisoning with chlorpyrifos,
was borderline significant for two conditions:
right leg (p = 0.10), and soft platform with
eyes open (p = 0.09). We found no associa-
tions with susceptible genotype. When we
compared applicators exposed before 1998 to
the nonexposed subjects, we found two sig-
nificant associations for more area of sway
(hard platform with eyes open, p = 0.03; soft
platform with eyes open, p = 0.05) and one
significant association for increased length of
sway (hard platform with eyes open, p =
0.10). The duration ofchlorpyrifos exposure
was significantly correlated with length of
sway for the right leg (p = 0.04) and was cor-
related near significance with sway on a hard
surfacewith eyes closed (p = 0.08).
No exposure variables were significantly
related to vertical tremor, horizontal tremor,
or the two combined, during any 1-min
period or over the whole 3-min test. The R2
values for the models for tremor were very
low, averaging only 1-2%.
Exposure did not decrease vibrotactile
sensitivity for either finger or toe (each was
tested at two different vibration frequencies,
31.5 and 125 Hz). Exposure was associated
with a significantly increased sensitivity for
the toe tested as 125 Hz. TCP was not a pre-
dictor of vibrotactile sensitivity. Former
applicators performed significantly better
than nonexposed subjects for the one-toe
test, as did the group with asusceptible geno-
type. The R2 values for the vibrotactile
models ranged from 0.05 to 0.18.
Clinical examination. The clinical
examination results showed no significant
differences between exposed and nonexposed
subjects for abnormal upper extremity
tremor (95 were abnormal with exposed and
Table 2. Exposure characteristics oftermiticide applicators (n = 191).
Characteristic
Applied termiticide in lastweek (n)
Median number(range) termitejobs in lastweek if any
Applied termiticide in current year(n)
Everapplied chlordane (n)
Median years (range) applied chlordane (n= 65)
Mean years(SD)applied chlordane (n= 65)
Median years (range) applied chlorpyrifos (n = 191)
Mean years (SD) applied chlorpyrifos (n = 191)
Median years applied other pesticides (n= 173)
Mean years (SD) applied other pesticides (n= 173)
Median (range) TCP level in urine (pg/L), termiticide applied in last week(n= 65)
Mean TCP level (SD) in urine (pg/L), termiticide applied in lastweek(n=65)
Median (range) TCP level in urine(pg/L), no termiticide applied in lastweek(n =40)b
Mean TCP level (SD) in urine (pg/L), no termiticide applied in lastweek(n=40)
Mean TCP level (SD; pg/L) in nonexposed subjects (n=52)c
Self-report of chlorpyrifos poisoning (n)
Value
76 (40%)
4(1-41)
128(67%)
65(34%)
4.5(0.5-28.5)
7.0(6.3)
1.8(0.1-10.3)
2.4 (2.2)
1.6(0.5-11.3)
2.5 (2.5)
172.7 (5.7-13,009)
629.5 1,636.6)a
28.1 (1-946)
119.0)196.)a
6.2 (6.1)a
8
'lhe creatinine-corrected values for applicators exposed in the lastweek, applicators notexposed in the lastweek, and
the nonexposed were 331, 55, and 3 pg/g creatinine, respectively. hlirine containers were mailed to all applicators who
reported applying termiticide when testing was scheduled, several weeks before the test date. However, many applica-
tors to whom we mailed specimen containers did not actually apply termiticide during the week before testing, but a
number of these did use chlorpyrifos in non-termite work (lawns or house interiors) during that week. cSimilar to the
mean level of 4.5 pg/L observed in a random sample of 929 U.S. adults (4).
nonexposed combined); abnormal toe, fin-
ger, wrist, ankle, or knee sensitivity to vibra-
tion (134, 54, 11, 66, and43 were abnormal,
respectively); abnormal sensation in response
to a pinprick in the arm or leg (24 and 11
were abnormal, respectively); abnormal gas-
troc soleus reflex (16 were abnormal), or
abnormal Romberg test (12 were abnormal).
The majority of subjects had at least one
abnormality (n = 208). Overall, the exposed
subjects had a significantly lower probability
ofanyabnormality than the nonexposed sub-
jects (p = 0.006), a finding that was consis-
tent for each individual nonexposed group.
On the other hand, the average number of
abnormalities (for each subject) did not differ
significantly between the exposed and nonex-
posed groups (p = 0.44).
The TCP level was not a significant pre-
dictor of any clinical outcomes. The eight
men who reported chlorpyrifos poisoning
had decreased wrist sensitivity to vibration (p
= 0.003) and decreased sensitivity to leg pin-
prick (p = 0.002). The 18 exposed men with
the susceptible genotype had increased odds
ofa abnormal gastroc soleus reflex (p = 0.01)
and an abnormal Romberg test (p = 0.04);
the latter finding was not seen on the analo-
gous computerized sway tests. Currently
exposed applicators had borderline higher
odds of an abnormal leg pinprick test (p =
0.08), whereas formerly exposed applicators
had borderline higher odds of an abnormal
gastroc soleus reflex.
Visuomotor tests: trails andpegboard.
The exposed group did not perform as well
as the nonexposed group in the pegboard
test for the dominant hand (p = 0.07). This
effect was apparent when the applicators
were compared to state employee controls (p
= 0.005) but not when applicators were
compared to nonexposed friends (p = 0.43).
Results were similar for the nondominant
hand, with respective p-values ofp = 0.09
(vs. both nonexposed groups), p = 0.02 (vs.
state employees), and p = 0.70 (nonexposed
friends). The eight applicators with self-
reported chlorpyrifos poisoning had a signif-
icant decrease in performance on the peg-
board test for the nondominant hand (p =
0.01) and a borderline decrease in perfor-
mance for the dominant hand (p = 0.09).
Former applicators performed less well for
the dominant hand test (p = 0.01). No
other exposure variables showed an effect
for the pegboard tests. The R2 values for
these tests were approximately 0.15.
Exclusion of seven outliers (scores > 200)
for the nondominant hand significantly
improved the fit.
There were no associations between any
exposure variable and either the trail A or
trail B test. The R2 values for these two
models were 0.16 and 0.32 respectively.
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Neurobehavioral tests. There were no
significant differences between the exposed
and nonexposed groups on most ofthe neu-
robehavioral tests (simple reaction time,
symbol-digit, continuous performance, digit
span, forward and backward, pattern memo-
ry, vocabulary). There was no significant dif-
ference in self-reported effort on these tests
between the exposed and nonexposed
groups. The J2 values for the exposed/non-
exposed models were 5%, 34%, 7%, 12%,
16%, 13%, and 31%, respectively, for these
tests. The level ofTCP did not significantly
predict performance on any of these tests
except for thevocabulary test, forwhich sub-
jects with more urinary TCP did significant-
lyworse (p = 0.02). In results ofthese tests in
exposed subjects, we found no significant
effects of current versus former exposure;
duration ofuse ofchlorpyrifos, chlordane, or
other pesticides; or presence ofa susceptible
genotype. Self-reported poisoning by chlor-
pyrifos was associated with decreases in per-
formance on the continuous performance
test (p = 0.0001) and on simple reaction
time (p = 0.06).
Of the five components that constitute
the mood scales, the exposed subjects report-
ed significantly more fatigue and tension
than the nonexposed subjects (p = 0.0002
and p = 0.01, respectively). The finding for
fatigue was significant for the applicators
versus each nonexposed group separately,
whereas the finding for tension was signifi-
cant for the applicators versus state employ-
ees (p = 0.007) but not versus nonexposed
friends (p = 0.14). The test for anger (p =
0.07) was borderline significant (vs. state
employee controls, p = 0.008). The test for
depression was significant for exposed sub-
jects versus nonexposed friends (p = 0.05)
but not versus state employees (p = 0.55).
The eight men who reported past chlorpyri-
fos poisoning reported significantly or bor-
derline significantly more anger (p = 0.06),
fatigue (p = 0.02), tension (p = 0.01), depres-
sion (p = 0.06), and confusion (p = 0.03).
Those with current chlorpyrifos exposure
reported significantly more fatigue (p =
0.0004) and tension (p = 0.02). No associa-
tions were found for genotype, by level of
TCP exposure, or byduration ofchlorpyrifos
exposure. The mood scales were correlated
with each other, with a Spearman correlation
coefficient usually on the order of0.50. The
2 values for mood scales were low, generally
approximately 5%.
Symptom questionnaire. The exposed
subjects reported significantly more symp-
toms than nonexposed subjects on 16 ofthe
24 questions about frequency ofsymptoms in
the last month. The exposed subjects more
often reported being tired, dizzy (2 items),
confused, less able to remember (3 items),
irritated, and less coordinated, and having a
loss ofstrength in limbs (4 items), headaches,
susceptibility to dizziness from chemicals, and
less tolerance for alcohol. We found border-
line significant findings (0.05 < p < 0.10) on
reported increased depression, worse concen-
tration, and numbness and tingling in toes.
The I2 values for linear models were low, on
the order of0.05; in the logistic models, few
variables other than exposure were predictive
of outcome. Several of the symptoms were
highly correlated with each other, particularly
for three related questions on remembering;
two questions about confusion and difficulty
concentrating; and four questions on loss of
strength in arms, hands, fingers, and legs
(pairwise Spearman correlation coefficients
0.40-0.60). Previously exposed applicators
were significantly different from the nonex-
posed subjects on 12 items, whereas currently
exposed applicators had nine significant asso-
ciations. The eight men reporting previous
chlorpyrifos poisoning had 10 significant
associations (tiredness, memory, irritability,
dizziness, understanding written material,
sleep problems, arm/hand/leg weakness, and
lack ofcoordination) and 1 borderline signif-
icant one (heart palpitations). The group of
18 applicators with genetic susceptibility had
asignificant association on only one test (lack
of coordination), and there were no signifi-
cant trends associated with TCP. The only
symptom showing a significantly increased
trend with duration ofchlorpyrifos exposure
was heart palpitations.
Vison t. Twenty-four participants were
found to have congenital loss ofcolorvision in
one or both eyes on the Farnsworth test and
were eliminated from the analysis ofacquired
colorvision loss viathe Lanthonytest.
The Lanthony test showed no difference
overall between exposed and nonexposed
subjects. However, there was a trend of
poorer color vision with increasing levels of
TCP for both the right (p = 0.006) and left
(p = 0.0008) eyes. This trend was significant
for the right eye onlybecause a single partici-
pant with a very high TCP level performed
poorly on the test. When we removed this
participant from the analysis, the regression
coefficient for each eye decreased 25%; the
coefficient was no longer significant for the
right eye (p = 0.47), but it remained signifi-
cant for the left eye (p = 0.006).
There was a correlation ofapproximately
0.70 between eyes for the Lanthony test, and
the the regression models explained approxi-
mately 12-14% of the variance of the data
(R2) foreither eye.
Visual acuity did not differ between the
exposed and nonexposed groups. The tests
ofvisual contrast, either overall or restricted
to those with good acuity (20/30 or better),
did not reveal any significant differences
between exposed and nonexposed groups for
either eye, nor was there any trend of
decreased performance with increases in the
urinary TCP level. We found no associations
between visual contrast and exposure for
subgroups of the exposed group (former,
current, susceptible genotype, poisoned
applicators) and no significant trends for con-
trast with duration of exposure to chlorpyri-
fos, chlordane, or other pesticides. Linear
regression models for acuity and contrast
explained only approximately 5% ofthe vari-
anceofthe data.
Smell tests. We found no differences in
the ability to correctly identify odors between
exposed and nonexposed groups; this ability
was not correlated with the TCP level. We
found no significant associations amongsub-
groups; the eight men who reported previous
chlorpyrifos poisoning did marginally better
on the smell tests (p = 0.08). I? values for
the linear models were approximately 0.05
for the smell tests.
Discussion
This study is the first large study of clinical
and subclinical neurologic effects of partici-
pants who have been exposed to chlorpyrifos.
This study has a number ofstrengths, includ-
ing a thorough evaluation ofneurologic func-
tion at both the dinical and subdinical level,
awell-defined exposed population, and alarge
sample size.
However, existing "objective" tests for
neurologic effects may not be adequate to
detect some effects caused by exposure. In
our study, exposed subjects reported signifi-
cantly more symptoms than nonexposed
subjects, but relatively few significant differ-
ences were found when more quantitative
tests were used.
The weaknesses ofour study include pos-
sible selection biases. We were able to recruit
only a minority ofthe exposed target popula-
tion, primarily because we could not locate
many subjects. However, we tested 69% of
eligible applicators whom we contacted. The
nature of any possible selection bias is not
clear: workers more affected by chlorpyrifos
may have preferentially participated; on the
other hand, workers most affected by expo-
sure may have left the workforce or been
harder to find, and thus did not participate.
One strength ofour study is that it was pop-
ulation-based and had a defined target popu-
lation; this tends to decrease selection biases.
We studied termiticide applicators
because they are exposed primarily to chlor-
pyrifos rather than other pesticides. However,
we found that termiticide applicators also
had substantial exposure to other pesticides
including chlordane, which preceded chlor-
pyrifos as the main pesticide used against ter-
mites. Nonetheless, in the analyses we found
Volume 108, Number 4, April 2000 * Environmental Health Perspectives 298Articles * Neurologic function after chlorpyrifos exposure
that exposure to chlordane or other pesti-
cides was not, in general, associated with
effects and therefore was unlikely to con-
found the analysis ofchlorpyrifos.
Our study population was ratheryoung-
90% ofthe applicators were under 50 years of
age. Ifchlorpyrifos causes delayed neurotoxic
effects that become apparent onlywith age, we
wouldhave missedsuch effects.
Table 3 provides a summary ofall results.
We found fewsignificant differences between
exposed and nonexposed subjects on the clin-
ical examination, with the exception of 2
(out of 10) tests that indicated increased
abnormality for the 8 men who reported
previous chlorpyrifos poisoning and 2 tests
for the 18 men with a susceptible genotype.
We also found no widespread pattern of
effects associated with exposure in most other
tests. However, there were exceptions to this
generally negative pattern. The exposed
subjects did not perform as well as the non-
exposed subjects on pegboard turning and
postural sway tests. Most markedly, the
exposed subjects consistently reported more
current psychologic and physical symptoms
than the nonexposed subjects. The differ-
ences between exposed and nonexposed sub-
jects for self-reported symptoms could have
been a true effect of exposure. One prior
study of chlorpyrifos-exposed subjects in a
manufacturing setting also found significant
increases in such ill-defined conditions (11),
and one study ofmen poisoned by chlorpyri-
fos (in combination with other organophos-
phates) found more severe self-reported mood
states than a nonpoisoned comparison group
(9). It is possible that there was a systematic
bias of applicators to overreport their symp-
toms, but we have no evidence to support
such a bias. The applicators did not, in gen-
eral, appear to complain about chlorpyrifos
during the testing sessions.
The differences in symptoms were more
marked for former rather than current appli-
cators, suggesting along-term effect. However,
these differences were generally not more
apparent for those with longer exposure to
chlorpyrifos. Future studies should consider
the temporal sequence of exposure and any
self-reported symptoms; welackeddataonthis
question because our questionnaire was limit-
ed to current symptoms.
We observed a pattern of worse perfor-
mance on several tests (sway, pinprick sensi-
tivity, self-reported physical and mental
symptoms, two neurobehavioral tests) by the
participants (n = 8) who reported chloripyri-
fos poisoning as compared with other
applicators. The data on poisoning are limit-
ed because oftheir self-reported nature; these
poisonings represent a past acute exposure
accompanied by self-reported symptoms
(only one of the eight men who reported
poisoning sought medical treatment).
Similar findings for self-reported negative
mood scales was also reported in a previous
study (9) for the subgroup with chlorpyrifos
poisoning. Our findings for the eight men
who reported chlorpyrifos poisoning suggest
that further study of the delayed effects of
chlorpyrifos poisoning arewarranted.
Applicators with a paraoxonase genotype
expected to increase sensitivity to the effects
of organophosphates (n = 18) showed few
positive effects, with the exception of two
tests on the clinical examination.
We studied applicators with a relatively
short duration of exposure (2 years) to
chlorpyrifos, possibly limiting our ability to
observe exposure effects. Furthermore, it is
possible that exposures were not sufficiently
high for an exposure effect to be observed.
However, 18% of the exposed subjects had
more than 4 years of exposure, and their
exposure levels (as indicated by urinary TCP)
were two orders of magnitude greater than
background levels in the U.S. population (4).
In summary, in this cross-sectional study
ofworkers exposed to chlorpyrifos, we found
few exposure-related effects for most tests,
including a clinical examination. However,
the exposed subjects did not perform as well
Table 3. Summary oftests (p-value) for which exposure effect had p-value <0.10.
6 NCV 12Sway 4VBT 10 Clinical 2Pegboard 6NB 5MS 24Symptom ACV loss Smell
testsa tests tests tests tests tests tests tests (2 eyes) test
Applicators 1 Length 1 Toe Betterodds, Dominant Fatigue, ten- 16 Tests,
(n= 191) vs. sway test test, better no abnormality hand (0.07) sion, anger, (<0.05; dizzy,
nonexposed (0.04) sensitivity (p= 0.0006) (0.001, 0.01 memory,
(n= 189) (0.03) 0.07) headaches,
fatigue, etc.),
3 tests
(<0.10)
Poisoned 1 Better 2 Area tests 2 Tests Dominant 1 Test10.0001) 5 Tests 10Tests(<0.05), Better
applicators amplitude (0.09, 0.10) (0.004, hand (0.01), 1 Test(0.06) (0.02, 0.06, 1 test(<0.10) (0.08)
(n=8)b (0.05) 0.003) nondominant 0.06, 0.01,
(0.09) 0.03)
Susceptible Velocity: 1 1 Better 2 Tests 2 Tests
genotype better(0.10), finger test (0.04,0.01) (0.04, 0.07)
(n= 18)b 1 worse (0.05)
(0.10)
Currently Current: 1 Former: 1 better Former and Former: Current: Former: 12
exposed length test toe test, current: 1 test dominant 2 tests (0.0004, tests (<0.05),
(n = 128) or (0.10); (0.04) worsefor each hand (0.01) 0.02) 1 test(<0.10);
formerly former: 1 length (0.07, 0.08) current: 9
exposed test(0.04) and tests <0.05),
(n=631b 2 area tests 3 tests (<0.10)
(0.03, 0.05)
Trend with 2 Length tests 1 Test (0.01)
duration (0.04, 0.08)
exposureb
Trend with 2 Length tests Vocabulary Both eyes
TCPb (0.03, 0.01) test (0.02) (0.006, 0.008)
Abbreviations: ACV, acquired color vision; MS, mood scales; NB, neurobehavioral; NCV, nerve conduction velocity; VBT, vibrotactile. Exposed subjects did not perform as well as unex-
posed subjects exceptwhere noted. We observed no significant differences in the two-arm tremortests,the trialstest, orthe vision contrast.
aVelocity and amplitude in three nerves. bPoisoned applicators, susceptible genotype applicators, current or former applicators each compared with nonexposed. Trend with duration
for applicators only. Trend with TCP among all participants with TCP data (105 applicators, 52 nonexposed).
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as the nonexposed subjects on pegboard
turning tests and some postural sway tests.
Furthermore, exposed subjects reported more
symptoms than nonexposed subjects; this is a
cause for concern because previous studies
(9,11) lend some support to this finding.
There was some suggestion of a pattern of
delayed effects for subjects with a past history
of poisoning, which is also supported by
some previous reports of men poisoned by
organophosphates (9,39,40). Although this
was a relatively large study based on a well-
defined target population, the workers we
studied may not be representative of all
exposed workers, and caution should be exer-
cised in generalizing our results.
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